Scientific images helped bring to life the discoveries made at Feinberg this year, from the origin of nitric oxide in the retina to mechanisms of herpes simplex virus infection. See a selection of some of the most stunning images.
Northwestern Medicine scientists have discovered two successful therapies that slowed the progression of pediatric leukemia in mice, the first step towards a pediatric leukemia “super drug.”
Two drugs commonly prescribed to treat Type 2 diabetes carry a high risk of cardiovascular events such as heart attack, stroke, heart failure or amputation, according to a new Northwestern Medicine study.
A drug called brentuximab vedotin combined with chemotherapy significantly improved overall survival for patients with a type of T-cell lymphoma, according to a clinical trial in The Lancet.
A new study aims to answer a resilience puzzle: Why second-hand experiences of neighborhood violence affect some youth, but not others.
Northwestern Medicine scientists have discovered that an enzyme called EZH2 can activate expression of the androgen receptor gene, which drives prostate cancer growth.
A human protein called RBBP6 helps fight the Ebola virus by interfering with the virus replication cycle, according to a study recently published in Cell.
Men with inflammatory bowel disease have four to five times higher risk of prostate cancer, according to a new 20-year study.
Inhibiting CHAF1B, a protein that normally helps replenish blood cells, may be a promising treatment for leukemia, according to a recent study.
Feinberg faculty, staff, students and community partners gathered at the inaugural IPHAM Population Health Forum to share their experience improving the health of communities in Chicago and around the world.